PETALUMA, Calif.--(BUSINESS WIRE)--Oculus Innovative Sciences, Inc. (Nasdaq: OCLS), a biopharmaceutical company that develops, manufactures and markets a family of products based upon the Microcyn® Technology platform, announced today that it has filed a patent application with the U.S. Patent and Trademark Office in which it seeks patent protection for a breakthrough wound care device.
